{"name": "Bavarian Nordic",
 "permalink": "bavarian-nordic",
 "crunchbase_url": "http://www.crunchbase.com/company/bavarian-nordic",
 "homepage_url": "http://www.bavarian-nordic.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Thu Jan 21 08:51:53 UTC 2010",
 "updated_at": "Thu Jan 21 08:55:26 UTC 2010",
 "overview": "\u003Cp\u003EBavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company\u0026#8217;s business strategy is focused in three areas: biodefence, cancer and infectious diseases.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       59],
      "assets/images/resized/0007/4283/74283v1-max-150x150.jpg"],
     [[250,
       99],
      "assets/images/resized/0007/4283/74283v1-max-250x250.jpg"],
     [[267,
       106],
      "assets/images/resized/0007/4283/74283v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.bavarian-nordic.com/investor/announcements/2009-26.aspx",
    "source_description": "Bavarian Nordic Enters Conditional Agreement for the Acquisition of Shares and Buy Back of Stock Options in its Subsidiary BN ImmunoTherapeutics Inc. in Order to Obtain 100% Ownership of the Subsidiary",
    "acquired_year": 2009,
    "acquired_month": 11,
    "acquired_day": 11,
    "company":
     {"name": "BN ImmunoTherapeutics",
      "permalink": "bn-immunotherapeutics",
      "image": null}}],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}